With our suite of solutions, de-risk and enhance clinical development and decision-making with the power of artificial intelligence.

Measure the likelihood of success for drugs across multiple therapeutic areas

Bolster internal risk identification with accurate AI-driven assessments

Pinpoint underlying drivers contributing to technical and regulatory risk

Explore risks influencing the drug development pipeline

Review the competitive landscape for acquisition, licensing and portfolio strategies

Detect predictive signals and optimize clinical trial design

Standardize risk evaluation processes across entire portfolios

Access a single source of quality, harmonized data for consistent risk evaluation
AI-Powered
Solutions Built With Comprehensive, Precise Data
Real-time tracking of clinical programs and features organized by proprietary ontologies

Expert data curation
and quality control by
biomedical professionals

Trusted by leading
pharma organizations
over legacy data sources
for PTRS/PoS calculations

Proven AI Accuracy With Advanced Algorithms
Accurate PTRS assessments validated retrospectively and prospectively at all clinical development stages

Actively tracked and validated real-world predictions

High prospective accuracy (>80%) vs. retrospective-only analyses of AI models

State-of-the-Art Explainable AI and Transparency
Transparency into PTRS predictions with hundreds of dimensions

Visualization of the drivers of PTRS predictions

Continuous innovation and investment with partner and customer feedback
